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EFFECTS OF PROCARBAZINE HYDROCHLORIDE ON THE GUINEA PIG THYMUS GLAND 
AND IMMUNOSUPPRESSION TO DINITROCHLOROBENZENE SENSITIZATION
CHAPTER I 
INTRODUCTION
Procarbazine hydrochloride (PH), a methyl hydrazine derivative, 
was originally introduced as an anti-neoplastic agent (6) and is consid­
ered one of the more active members of the group of synthetic cytotoxic 
compounds derived from methyl hydrazine (12). The trade names for procar­
bazine hydrochloride have been Natulan, Matulane and in earlier publica­
tions i t  was referred to as methyl hydrazine derivative, Ro-4-6467 or 
Ibenzmenthizine (77).
The mechanism of action of procarbazine is uncertain. In vitro 
studies (12) have demonstrated its ability to inhibit the synthesis of 
protein, RNA and DNA. In vitro analysis has demonstrated that cytotoxic 
derivatives of methyl hydrazine can degrade DNA through a mechanism involv­
ing the auto-oxidation of the methyl hydrazine to hydrogen peroxide (81). 
Berneis, e t ^ . , (4) have proposed that procarbazine in vivo may break 
down to form formaldehyde, azomethine, N-hydroxymethyl derivatives and in 
agreement with in vitro studies the release of hydrogen peroxide. The in 
vivo growth inhibiting effects of procarbazine may be caused by both oxi­
dation and alkylation of cellular constituents (4). Kreis and Yen (51)
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have shown in vivo N-detnethylation of procarbazine. Kreis (50) has also 
demonstrated a selective effect of the compound on the méthylation of 
transfer RNA and has suggested that this may contribute to its  carcino- 
static activity.
Procarbazine has been demonstrated to be an effective anti-tumor 
agent in animals (6, 70) and in man. In man i t  has received emphasis 
when used alone (5, 7, 9, 12, 19, 20, 25, 26, 27, 39, 43, 61, 62, 80, 84, 
87) or in combination with other (10, 11, 18, 19, 36, 56, 66, 78) chemo­
therapeutic agents for the treatment of Hodgkin's disease. The effect­
iveness of procarbazine in combination with radiotherapy for the treat­
ment of Hodgkin's disease (2, 64, 75) and of solid tumors (52) has been 
demonstrated.
As with other anti-neoplastic drugs procarbazine is also known 
to induce severe adverse reactions. Kelly, et ^ . , (48) and others (22, 
69) have demonstrated the ability of procarbazine to induce neoplasms in 
animal models. Other adverse reactions which have been attributed to 
procarbazine hydrochloride treatment have included toxic effects on the 
hematopoietic tissue (30), the cardiovascular (42), and the central 
nervous system (42) and its ability to induce allergic hypersensitivities 
(21, 47, 55).
Procarbazine hydrochloride is similar to other anti-tumor agents 
in that i t  has been demonstrated to be an effective immunosuppressive 
agent. The immunosuppressive characteristics of procarbazine hydrochlor­
ide have been demonstrated: a) to suppress the humoral immune response 
(77, 85); b) to suppress adjuvant induced autoimmune disease (77); c) to 
prolong acceptance of human renal transplants (73); d) to prolong survi-
val of xenografts (16, 44); e) to increase graft survival when there is 
pretreatment of graft donors (37, 38, 88, 89); f) to enhance immunosup­
pression when given in combination with anti-lymphocyte serum (31); g) to 
abrogate the graft-versus-host reaction (35).
Stewart and Bell (85), Floersheim, (29) and Possanza and Stewart 
(74), have demonstrated optimal immunosuppressive effects for PH when 
given for 21 days prior to exposure to the antigen. Quagliata, et ^ . , 
(77) and Floersheim, et ^ . , (32) have demonstrated the lymphotoxic ef­
fects of methyl hydrazine derivatives on cortical thymic lymphocytes. In 
rats (57, 77) and mice (29, 86), PH has been reported to suppress or 
completely abolish thymus-dependent but not thymus-independent immunity. 
Although the immunosuppressive and tolerance levels of PH have been re­
ported for rats, mice, and rabbits (85), comparable information has not 
been reported for guinea pigs.
Taking into consideration the importance of pretreatment, thymus 
destruction and the effectiveness of PH on thymus-dependent immunity, the 
present study was designed with the following objectives: a) to deter­
mine an effective immunosuppressive dose level of PH for guinea pigs; 
b) to determine by light and electron microscopy the sequential morpho­
logical alterations of the thymus during PH treatment; c) to demonstrate 
by dinitrochlorobenzene skin sensitization the degree of cell-mediated 
immunosuppression induced by chronic PH treatment; d) to correlate the 
recovery from immunological suppression with the morphological changes 
in the thymus.
CHAPTER I I
MATERIALS, METHODS AND EXPERIMENTAL DESIGN 
Materials 
Animals
Hartley strain female guinea pigs obtained from Camm Research 
Institute, Inc., (414 Black Oak Ridge Road, Wayne, New Jersey) were u ti­
lized in the following studies. Upon arrival, the young adult animals 
weighing 400-450 grams were placed on a routine diet and housed in semi­
isolation for at least one week before assignment to study groups. Once 
assigned, all animals were weighed daily and examined for overt manifest­
ations of disease.
Prophylactic antibiotics were never administered to immunologi- 
cally suppressed or to control animals.
Immunosuppressant 
Procarbazine hydrochloride. The commercial name for the immuno­
suppressant procarbazine hydrochloride (PH) is Matulane (Hoffman-LaRoche, 
Inc., Nutley, New Jersey).
Skin Sensitizer and Skin Test Antigen 
l-Chloro-2, 4-Dinitrobenzene. The skin sensitizer and skin test
antigen l-chloro-2, 4-dinitrobenzene (DNCB) was obtained from Eastman 
Kodak Co., (Rochester, New York).
Methods
Preparation and Application of Procarbazine Hydrochloride 
Procarbazine hydrochloride (PH). To yield the dosage levels 
required by a particular experimental protocol PH was quantitatively 
measured for each experimental animal and solubilized in 0.5 ml of ster­
ile  distilled water. This volume of the freshly prepared aqueous PH was 
injected subcutaneously into the dorsal scapular region of each test 
animal. The total number of injections was determined by the experimen­
tal design.
Evaluation of the Immune Response 
Skin homografts. An area on the back of a donor guinea pig was 
shaved and the animal sacrificed by cervical dislocation. A full-thick­
ness graft was removed and placed in a sterile petri dish containing 
Eagle's Minimum Essential Medium (Auto-Pow; Flow Laboratories) with 100 
units of penicillin and 100 micrograms of streptomycin per ml (Gibco). 
The recipient was anesthesized with pentobarbitoi (4 mg/100 gm body 
weight), the back shaved, and a 5/8 inch square skin graft bed exposed.
A graft of comparable size was taken from the donor specimen, placed in 
the graft bed and secured with 5-0 suture.
Immunological skin testing. Both lumbar quadrants of a ll test 
animals were shaved 24 hours before the in itia l application of antigen. 
The skin sensitizing antigen consisted of a 2.0% solution of l-chloro-2, 
4-dinitrobenzene (DNCB) in absolute ethanol. Six drops of the sensitiz-
ing antigen, delivered through a 26 gauge needle, was topically applied 
to a single site within the shaved area. All sensitized animals received 
7 daily applications of DNCB.
Skin testing was performed in the same general anatomical region 
however test sites were not superimposed on the site of DNCB sensitiza­
tion. Twenty-four hours prior to skin testing, the area was reshaved and 
four individual test sites labeled. Test sites 1, 2, and 3 were for skin 
test evaluations at 24, 48, and 72 hours respectively. The skin test 
itse lf was performed by placing 1 drop of 0.5% DNCB dissolved in absolute 
ethanol on test sites 1, 2, and 3. Test site 4 was used as a control for 
the solvent and received 1 drop of pure absolute ethanol only.
Visual evaluation of skin test sites was performed at 24, 48, 
and 72 hours after application of the skin test antigen. The diameter 
of skin test sites was measured and graded for degree of induration. A 
grading system was devised to convert the degree of induration and mono­
nuclear cell infiltration to a numerical value. A conversion scale is 
provided in Table 5.
Histological evaluation was performed on biopsy specimens taken 
from skin test sites 1, 2, and 3. Biopsies of test sites 1, 2, and 3 
were taken at 24, 48, and 72 hours respectively and the specimens pre­
served for light microscopic examination.
Microscopic Examination 
Thymus collection and preservation. Animals were sacrificed by 
cervical dislocation and both lobes of the thymus collected for light 
and electron microscopic examination. Each thymic lobe was divided into
equal parts by a parasagittal cut and one half of each lobe was processed 
for light microscopy. The remaining half of each lobe was prepared for 
electron microscopy.
Light microscopy. Tissues (thymus and skin) were fixed in 10% 
neutral buffered formalin and routinely processed in paraffin. Three 
micron sections were stained with hematoxylin and eosin.
Electron microscopy. The thymus half lobes (right and le ft) 
were fixed in 4% cacodylate buffered gluteraldehyde pH 7.4 for 24 hours 
at 4° C. Following fixation the tissues were temporarily stored in 
sucrose buffer at 4° C before being post-fixed in Palade's (72) osmium 
mixture for 1 hour. Tissues were then washed in veronal buffer, dehy­
drated in 70, 95, and 100% ethanol, cleared in propylene oxide and placed 
in a 1:1 mixture of propylene oxide and 6:4 Epon. Tissues were then 
infiltrated and embedded in pure 6:4 Epon. Gelatin capsules containing 
the Epon embedded tissues were polymerized for 24 hours at 60° C.
Thick sections of Epon embedded material were used to verify 
the precise location of the EM specimen within the thymus gland, i.ie ., 
subcapsular, cortex, medulla, corticomedullary junction. Thick sections 
(2000 A) were heat dried on glass slides, stained with 1% crystal violet 
and examined light microscopically.
Thin sections producing a gold-silver interference color were 
cut on a Porter Blum MT 2 ultramicrotome. Sections were collected on 
#300 mesh copper grids, stained with uranyl acetate and lead citrate, 
and examined on a RCA EMU-3F electron microscope.
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Experimental Design 
The PH dose level tolerated by other animal species can not be 
correlated with their size or weight, therefore preliminary studies were 
necessary to determine both the tolerance (LD̂ q) and the optimum immu­
nosuppressive levels for guinea pigs.
The following experiments utilizing animal Groups I and I I  were 
designed to obtain this information.
To facilitate the recording of complex treatment schedules and 
the arrangement of data in tabular form, the following numbering system 
was used throughout all subsequent studies. Numbers preceded by a minus 
sign (-) indicate the days of pretreatment with PH or water before eval­
uation of the immune response by skin grafting or skin sensitization. 
Numbers preceded by a plus sign (+) indicate the day or days of any pro­
cedure following pretreatment with PH or water, i .e . ,  skin grafting, 
supplemental injections, DNCB sensitization, skin testing, or sacrifice.
Study I - Animal Group I 
The 8 animals in Group I were divided into 4 equal subgroups,
A, B, C, D. Experimental animals in subgroups A, B, and C received dif­
ferent dosage levels of PH solubilized in 0.5 ml of sterile distilled  
water; control animals in subgroup D received sterile water only. All 
animals were weighed daily and examined for gross toxic effects, e .£ ., 
physical signs of anemia (paleness of eyes and ears) and respiratory 
symptoms.
Experimental animals. Animals in subgroups A, B, and C received 
15, 35, and 55 mg/Kg of PH respectively. After 21 daily injections (days 
-21 ^ -1), the degree of immunosuppression in surviving animals was eval-
uated by fullthickness skin homografts on day +1. Each experimental 
animal received three supplemental PH injections on days +2, +4, +6 
before sacrifice on day +7.
Control animals. Subgroup D animals receiving 0.5 ml of sterile  
distilled water only followed the same time schedules of pretreatment, 
grafting, supplemental injections, and sacrifice as experimental animals.
The injection schedules, PH dosage levels and numbers of animals 
utilized in each group are summarized in Table 1.
Study I I  - Animal Group I I
Information obtained from the previous study indicated that the 
optimum PH dosage level for guinea pigs was more than 15 mg/Kg but less 
than 35 mg/Kg. The results also indicated that the skin grafting proced­
ure used for evaluating the immune response was unsatisfactory for the 
debilitated PH-treated animals.
In the following experiment, an intermediate dosage level of PH 
was selected, the number of supplemental injections was increased, and 
immunological skin testing was instituted for evaluating the degree of 
immunosuppression.
Experimental animals. PH treated animals in Group II-A received 
25 mg/Kg in 0.5 ml of sterile water. After 21 daily injections, animals 
were sensitized on seven consecutive days (days +1 -»■ +7) with topically 
applied DNCB. Experimental animals received six supplemental PH injec­
tions after the f irs t day of exposure to DNCB. Supplemental injections 
were given every other day (days +2, +4, +6, +8, +10, +12) during and in 
the period immediately following DNCB sensitization, The effectiveness 
of this sequence of PH treatment in suppressing the Immune response was
TABLE 1 
STUDY I
PROTOCOL FOR DETERMINATION OF DOSE TOXICITY LEVELS TOLERATED BY 




















Sacri f i  ced
I-A 2 15 -21  -4-  -1 +1 +2 +4 +6 +7
I-B 2 35 -21  -1 +1 +2 +4 +6 +7
I-C 2 55 -21  _l +1 +2 +4 +6 +7
I-D 2 None -21  -1 +1 +2 +4 +6 +7
® Procarbazine hydrochloride,
 ̂ Milligram per kilogram of whole body weight.
n
evaluated by skin testing 28 days after the firs t exposure to DNCB. Skin 
test sites were examined at 24 and 48 hours after application of the skin 
test antigen. Animals were sacrificed immediately after the 48 hour 
test reading and the thymus collected for histological examination.
Control animals. Group II-B animals receiving only distilled  
water were injected, immunized, skin tested, and sacrificed as were the 
experimental animals.
A detailed experimental protocol, including the animal numbers 
for Group I I  is summarized in Table 2.
Study I I I  - Animal Groups I I I ,  IV, V
Results obtained from Study II allowed the maximum tolerated PH 
dosage of 25 mg/Kg, without undue toxicity, to be used in Studies I I I  and 
IV. These animal groups were utilized only to evaluate the sequence of 
morphological changes occurring in the thymus during PH treatment. The 
letter "A" following a group number indicates PH treated animals receiv­
ing 25 mg/Kg in 0.5 ml sterile distilled water. The letter "B" following 
the group number indicated the corresponding control groups receiving 
0.5 ml of sterile water only.
Experimental animals. Groups III-A , IV-A and V-A received daily 
injections of PH (25 mg/Kg) for 7, 14, or 21 days respectively. Animals 
in each group were sacrificed 24 hours following the last injection and 
the thymus preserved for light and electron microscopic examination.
Control animals. Groups III-B , IV-B, and V-B corresponding to 
the above experimental groups received daily injections of sterile water 




PROTOCOL FOR EVALUATION OF TOXICITY AND IMMUNOSUPPRESSION IN GUINEA 






T rea tm en t
with:
Days T re a te d  














Days o f  
Skin Test 
Evaluations
II-A 8 PH*̂ -21 4. _i +1 4- +7 +2 +4 +6 
+8 +10 +12
+28 +29 +30 +31
II-B 4 HgO -21 4. _i +1 4- +7 +2 +4 +6 
+8 +10 +12
+28 +29 +31 +31
ro
® l-Chloro-2, 4-Dinitrobenzene. 
“ Procarbazine hydrochloride.
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Table 3 contains the injection schedules for experimental and 
control animals in Groups I I I ,  IV, and V and includes the numbers of 
animals included in each group.
Study IV - Animal Groups VI, V II, V I I I ,  IX 
Study IV was designed to determine the duration of immunosupres- 
sion and to correlate the immune recovery with sequential changes in 
thymic morphology. The duration and recovery rates were evaluated by 
skin testing DNCB sensitized animals at 0, 7, 14, and 21 days following 
the last exposure to the sensitizing antigen. All animals were sacrificed 
after the 72 hour skin test reading and the thymus preserved for light 
and electron microscopic examination.
Experimental animals. Groups VI-A, VII-A, VIII-A and IX-A 
received daily injections of PH (25 mg/Kg) for 21 days. Sensitization 
was begun 24 hours later when the animals received the firs t of seven 
daily applications of DNCB (days +1 +7). During the seven days of sen­
sitization, the experimental animals in all four groups received three 
additional PH injections on days +2, +4, +6. Experimental animals in 
Group VI-A were skin tested on the last day of sensitization to obtain 
a zero time interval. The remaining experimental groups received three 
additional PH injections on days +8, +10, +12 for a total of six supple­
mental injections. Animals in Groups VII-A, V III-A , and IX-A were skin 
tested on days +14, +21, and +28 respectively to obtain the required 
time intervals of 7, 14, and 21 days.
Control animals. Groups VI-B, VII-B, V III-B , and IX-B received 
water injections and followed the time schedules described for the corre­
sponding experimental groups. Sensitization, skin test time intervals.
14
TABLE 3 
STUDY I I I
SCHEDULE FOR SEQUENTIAL MICROSCOPIC EXAMINATION OF THYMUS TISSUE 







Treatment Days Treated , 




III-A 5 PĤ -7 4. -1 +1
III-B 3 HgO -7 4- -1 +1
IV-A 5 PH -14 4- -1 +1
IV-B 3 HgO -14 4- -1 +1
V-A 5 PH -21 4. -1 +1
V-B 3 HgO -21 4. -1 +1
* l-Chloro-2, 4-Dinitrobenzene. 
Procarbazine hydrochloride.
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evaluation and sacrifice procedure were identical to those of experi­
mental animals.
A complete experimental protocol including animal numbers for 
each group is summarized in Table 4.
TABLE 4 
STUDY IV
SCHEDULE FOR SEQUENTIAL EVALUATION OF IMMUNOSUPPRESSION 
AND MICROSCOPIC EXAMINATION OF THYMUS TISSUE OF 
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VIII-A 5 PH -21 -1 +1 -*■  +7 +2 +4 +6 
+8 +10 +12
14 +28 +22 +23 +24
VIII-B 3 HgO -21 -1 +1 -*■  +7 +2 +4 +6 
+8 +10 +12
14 +28 +22 +23 +24
IX-A 10 PH -21 -1 +1 ^ +7 +2 +4 +6 
+8 +10 +12
21 +28 +29 +30 +31
IX-B 5 HgO -21 -V -1 +1 +7 +2 +4 +6 
+8 +10 +12





NUMERICAL GRADING SYSTEM FOR DEGREE OF INDURATION AND 
















"Medium"-Strong 3.50 "Medi um"-Strong
"Strong"-Strong 3.75 "Strong"-Strong
CHAPTER I I I  
RESULTS
Experimental and control animals were evaluated by physical, 
immunological and histological means. All animals were weighed and exam­
ined daily for signs of illness and the PH treated animals were observed 
closely for signs of drug toxicity, i_.ê ., suppressed weight gain, indi­
rect evidence of anemia (paleness and extramedullary hematopoiesis), res­
piratory distress, lethargy and death.
Toxic Effects of Procarbazine Hydrochloride Treatment
Most PH treated animals displayed some evidence of drug toxicity. 
The earliest physical manifestation of toxicity was weight change which 
became more severe as the dosage level was increased. Additional toxic 
effectsanemia and respiratory symptoms, appeared somewhat later and 
could be correlated with the dose level and with the duration of treat­
ment. Early stages of anemia and respiratory distress appeared to be 
reversible and usually disappeared after completion of the PH injection 
sequence, but the later stages were frequently irreversible. High levels 
of PH administered for prolonged periods produced more devastating effects 
progressing to lethargy and terminating in death.
Weight Changes
Study I. Three PH dosage levels (15, 35, and 55 mg/Kg) were u ti-
19
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11 zed in an attempt to determine both the tolerance and acceptable immu­
nosuppressive levels for guinea pigs. Animals receiving 15 mg/Kg exhi­
bited no physical signs of toxicity except for a slight reduction in the 
rate of weight gain (growth). Experimental animals receiving 35 and 55 
mg/Kg were overtly toxic and exhibited an actual weight loss rather than 
a reduction in the rate of weight gain. Animals receiving the highest 
dosage levels (55 mg/Kg) did not survive the anesthesization procedure 
required for full thickness skin homografts.
Study I I .  An intermediate PH dosage level of 25 mg/Kg was used 
in an attempt to reduce overt toxicity while maintaining an adequate 
level of immunosuppression. Experimental animals exhibited a marked de­
crease in the rate of weight gain when compared to control animals (Table 
6). Although this dosage produced a marked reduction in the rate of 
weight gain, the treated animals exhibited minimal evidence of other toxic 
symptoms.
Studies I I I  and IV. After the firs t week of PH treatment, all 
experimental animals receiving 25 mg/Kg exhibited a continuous weight 
gain, but the average increase was less than that exhibited by the corre­
sponding control groups (Table 7). During the f irs t week however, exper­
imental animals in groups IV-A, V-A, and VII-A and the control animals 
in group V-B exhibited a transitory weight loss. Animals exhibiting a 
prolonged and severe weight loss almost invariably died prior to comple­
tion of the PH injection schedule.
Mortality
In studies I I I  and IV, in which the experimental animals received 
25 mg/Kg, some deaths occurred (15%) (Table 8). All deaths occurred in
TABLE 6
WEIGHT CHANGE OF ANIMALS IN STUDY I I  TREATED WITH 
25 mg/Kg DOSES OF PROCARBAZINE HYDROCHLORIDE
Animal
Group -1 -7 -14
Days of Experiment 
-21 +7 +14 +21 +28
II-A a 467 469 499 509 514 526 539 532
b 0 +2 +32 +42 +47 +59 +72 +65
II-B a 453 476 517 547 574 608 614 614
b 0 +23 +64 +94 +121 +155 +161 +161
ro
® Mean body weight on days indicated.
Mean weight change from in it ia l average weight on day -1.
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TABLE 7
WEIGHT CHANGE OF ANIMALS IN STUDIES I I I  AND IV TREATED 
WITH 25 mg/Kg DOSES OF PROCARBAZINE HYDROCHLORIDE
Animal
Groups -1 -7 -14
Days of Experiment 
-21 +7 +14 +21 +28
III-A a 403 403
b 0 0
III-B a 415 432
b 0 +17
IV-A a 416 400 450
b 0 -16 +34
IV-B a 435 440 509
b 0 +5 +74
V-A a 406 389 415 430
b 0 -17 +9 +24
V-B a 416 414 465 490
b 0 -2 +49 +74
VI-A a 435 457 504 523 506
b 0 +22 +69 +88 +71
VI-B a 408 453 511 533 564
b 0 +45 +103 +125 +156
VII-A a 442 439 447 455 454 465
b 0 -3 +5 +13 +12 +23
VII-B a 425 431 476 503 545 569
b 0 +6 +51 +78 +120 +144
VIII-A a 425 428 461 475 478 469 496
b 0 +3 +36 +50 +53 +44 +71
VIII-B a 475 516 540 591 632 672 700
b 0 +41 +65 +116 +157 +197 ,+225
IX-A a 492 493 514 525 523 513 536 555
b 0 +1 +22 +33 +31 +21 +44 +63
IX-B a 483 519 548 598 629 667 701 723
b 0 +36 +65 +115 +146 +184 +218 +240
J Mean body weight on days indicated.
°  Mean weight change from in itia l average weight on day -1.
23
TABLE 8



















III-A 7 7 5 0 5
III-B 0 7 3 0 3
IV-A 14 14 5 0 5
IV-B 0 14 3 0 3
V-A 21 21 5 1 4
V-B 0 21 3 0 3
VI-A 24 31 5 1 4
VI-B 0 31 3 0 3
VII-A 27 38 5 0 5
VII-B 0 38 3 0 3
VIII-A 27 45 5 1 4
VIII-B 0 45 3 0 3
IX-A 27 52 10 3 7
IX-B 0 52 5 0 5
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animals receiving 21 or more PH injections. Of these deaths, two-thirds 
occurred in animals undergoing the longest duration of treatment (groups 
VIII-A and IX-A). No deaths occurred in the control animal groups.
Evaluation of Immunity 
Homografts
Study I. The method, fu ll thickness skin homografts, used to 
evaluate the effectiveness of PH immunosuppression was found to be unsat­
isfactory for the debilitated PH treated animals.
Skin Testing
Study I I .  In this study, skin testing of DNCB sensitized ani­
mals was instituted as the method for evaluating the effectiveness of 
PH as an immunosuppressant of cell-mediated immunity. Skin tests perform­
ed on experimental animals treated with 25 mg/Kg of PH indicated a marked 
immunosuppression (Table 2). When compared to control animals, the skin
test diameters of PH treated animals were decreased by 20-30% at 24 hours
and 40-60% at 48 hours (Table 9). The PH treated animals also exhibited 
a degree of skin test induration which was approximately 53% and 57% less 
than the controls at 24 and 48 hours respectively (Table 10).
Since experimental animals receiving 25 mg/Kg of PH exhibited 
marked immunosuppression while manifesting minimal degrees of drug toxi­
city, this dosage level was utilized in Studies I I I  and IV to produce 
the suppressed state. Furthermore, since skin testing proved to be a 
satisfactory method for evaluating the degree of immune suppression, this 
method was retained for assessing the rate of immune recovery in Study IV.
Study IV. Skin test sites in animal groups VI, V II, V III ,  and
25
TABLE 9
RESULTS OF SKIN TEST DIAMETERS IN ANIMALS IN STUDY I I  TREATED WITH 





Day of DNCB 
Sensitization 
and Time of 
Skin Testing
Percent Decrease 
between PH and 
Water Treated 
Animals at:®
24 hrs. 48 hrs.
Accumulative Percent 
Decrease between PH 
and Water Treated 
Animals at:
(24 + 48 hrs.)
I I 21 23 42 32
® Mean values of all animals in designated group: Mean of Group A 
divided by Mean of Group B.
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TABLE 10
RESULTS OF SKIN TEST INDURATION IN ANIMALS OF STUDY I I  TREATED 
25 mg/Kg DOSES OF PROCARBAZINE HYDROCHLORIDE
Animal Time Interval Percent Decrease Accumulative
Group between Last between PH and Percent Decrease
Day of DNCB Water Treated between PH and
Sensitization Animals at:®*“ Water Treated
and Time of Animals
Skin Testing 24 hrs. 48 hrs. (24 + 48 hrs.)
I I 21 53 57 55
Mean values of all animals in designated group: Mean of Group A 
divided by Mean of Group B.
Numerical values used to calculate the differences in degrees of 
induration were obtained from table 5 which converts the subjective 
grading to a numerical one.
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IX were evaluated for diameter of erythema, for degree of induration, 
and for mononuclear cell infiltration.
Using the accumulative mean percentage values for the e;<peri- 
mental and for the control animals, the greatest difference between skin 
test diameters occurred when the animals were skin tested at day 0 time 
interval post-sensitization (Table 11); the greatest difference in degree 
of induration occurred when the animals were skin tested at day 14 post­
sensitization (Table 12) (Figures 1-6); the greatest difference between 
degree of mononuclear cell infiltration occurred when the animals were 
skin tested at day 7 post-sensitization (Table 13) (Figures 7-12).
Microscopic Examination of Thymus Tissue
Light Microscopy - Study I I I
Tissue for microscopic evaluation was obtained from animals 
groups I I I ,  IV, and V. These animals received PH or water for 7, 14, or 
21 days prior to sacrifice.
Control animals. The thymic cortex of control animals receiving 
7, 14, or 21 daily injections of water were thick and crowded with thymic 
lymphocytes (Figures 13, 15, 17, 23, 25, 27). The cellular population 
consisted of a mixture of small, medium, and large sized lymphocytes 
(Figures 23, 25, 27, 33, 35, 37) and contained an impressive number of 
large cortical lymphocytes (Figures 33, 35, 37).
The corticomedullary Junction of control animals was distinct 
and sharply delineated (Figures 13, 15, 17).
Medullary regions of the control animals contained typical thy­
mic corpuscles and were composed of a mixture of epithelial and lymphoid 
cells (Figures 43, 45, 47).
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TABLE n
RESULTS OF SKIN TEST DIAMETERS IN ANIMALS OF STUDY IV TREATED WITH 
25 mg/Kg DOSES OF PROCARBAZINE HYDROCHLORIDE
Animal Time Interval Percent Decrease Accumulative
Group between Last between PH and Percent Decrease
Day of DNCB Water Treated between PH and
Sensitization Animals at:® Water Treated
and Time of Animals at:
Skin Testing 24 hrs. 48 hrs. 72 hrs. (24 + 48 + 72 hrs.)
VI 0 36 29 54 41
VII 7 +5* 21 15 10
VIII 14 30 25 22 26
IX 21 26 14 7 16
® Mean values of all animals in designated group: Mean of Group A
divided by Mean of Group B.
* This value designates an increase rather than a decrease.
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TABLE 12
RESULTS OF SKIN TEST INDURATION IN ANIMALS OF STUDY IV TREATED WITH 
25 mg/Kg DOSES OF PROCARBAZINE HYDROCHLORIDE
Animal Time Interval Percent Decrease Accumulative
Group between Last between PH and Percent Decrease
Day of DNCB Water Treated. between PH and
Sensitization Animals at:®*° Water Treated
and Time of Animals at:
Skin Testing 24 hrs. 48 hrs. 72 hrs. (24 + 48 + 72 hrs.)
VI 0 30 37 71 46
VII 7 38 10 27 25
V III 14 48 53 61 54
IX 21 45 49 45 46
a
b
Mean values of all animals in designated group: Mean of Group A 
divided by Mean of Group B.
Numerical values used to calculate the differences in degrees of 
induration were obtained from Table 5 which converts the subjective 
grading to a numerical one.
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TABLE 13
RESULTS OF SKIN TEST CELLULAR INFILTRATION IN ANIMALS OF STUDY IV 
TREATED WITH 25 mg/Kg DOSES OF PROCARBAZINE HYDROCHLORIDE
Animal Time Interval Percent Decrease Accumulati ve
Groups between Last between PH and Percent Decrease
Day of DNCB Water Treated between PH and
Sensitization Animals at:®»“ Water Treated
and Time of Animals at:
Skin Testing 24 hrs. 48 hrs. 72 hrs. (24 + 48 + 72 hrs.)
VII 7 67 45 27 46
V III 14 +11* 11 22 7
IX 21 28 17 8 18
Mean values of all animals in designated group: Mean of Group A 
divided by Mean of Group B.
Numerical values used to calculate the differences in degrees of 
cellular infiltration were obtained from Table 5 which converts the 
subjective grading to a numerical one.
This value designates an increase rather than a decrease.
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Figure 1. Representation of induration graded as "None-Observed" 
(Numerical conversion value of 0.00). No skin test 
activity is demonstrable at test sites 1, 2, or 3. The 
control test site (ST 4) is covered by the animal label. 
The dark areas at ST 1, ST 2, and ST 3 are India ink used 
to mark test sites.
Figure 2. Representation of induration graded as "Medium"-Light
(Numerical conversion value of 1.50). Skin test sites 2 
and 3 demonstrate "medium"-light induration. The brown 
color at ST 4 is India ink. St 1 was biopsied at 24 
hours and is covered with the animal label.
Figure 3. Representation of induration graded as "Strong"-Light 
(Numerical conversion value of 1.75). Test sites 1, 2, 
and 3 demonstrate "strong"-light induration which is best 
observed at ST 2. The control site (ST 4) is covered 
with the animal label.
Figure 4. Representation of induration graded as "Medium"-Medium 
(Numerical conversion value of 2.50). Test sites 1, 2, 
and 3 demonstrate "medium"-medium induration which is best 
observed at ST 2 and ST 3. The brown color at sites 2, 3 
and 4 are India ink.
Figure 5. Representation of induration graded as "Strong"-Medium 
(Numerical conversion value of 2.75). Test sites 1, 2, 
and 3 demonstrate "strong"-medium induration. The dark 
color at the control site (ST 4) is India ink.
Figure 6. Representation of induration graded as "Medium"-Strong 
(Numerical conversion value of 3.50). Skin test sites 
1, 2, and 3 demonstrate "medium"-strong induration which 
is best observed at ST 2. The dark areas adjacent to 
sites ST2 and ST 4 are India ink. The sensitizing site 
(SS) is also shown in this figure.
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ST 1 Skin test site biopsied at 24 hours.
ST 2 Skin test site biopsied at 48 hours.














Figure 7. Representation of mononuclear cell infiltration graded as
"Medium"-Light (Numerical conversion value of 1.50).
H&E 170X
Figure 8. Representation of mononuclear cell infiltration graded as
"Strong"-Light (Numerical conversion value of 1.75).
H&E 170X.
Figure 9. Representation of mononuclear cell infiltration graded as
"Medium"-Medium (Numerical conversion value of 2.50).
H&E 170X.
Figure 10. Representation of mononuclear cell infiltration graded as
"Strong"-Medium (Numerical conversion value of 2.75).
H&E 170X.
Figure 11. Representation of mononuclear cell infiltration graded as
"Medium"-Strong (Numerical conversion value of 3.50).
H&E 170X.
Figure 12. Representation of mononuclear cell infiltration graded as






Experimental animals. The thymic cortex of animals receiving 
7, 14, or 21 daily injections of PH were depleted of thymic lymphocytes 
(Figures 14, 16, 18, 24, 26, 28, 34, 36, 38). As the duration and number 
of PH injections increased, the severity of lymphocyte depletion increased 
(Figures 14, 16, 18, 24, 26, 28). Depletion was particularly pronounced 
in animals receiving PH for 21 days (Figures 18, 28). Cortical depletion 
involved small, medium, and large sized lymphocytes (Figures 24, 26, 28, 
34, 36, 38).
Corticomedullary junctions in PH treated animals were somewhat 
diffuse and d ifficu lt to define (Figures 14, 16, 18, 24, 26, 28).
The medullary regions of PH treated animals did not exhibit a 
marked reduction in the number of cells (Figures 14, 16, 18, 44, 46, 48), 
but some alterations were evident. These changes were most evident in 
animals treated for 21 days and consisted of a slight reduction in the 
number of medullary lymphocytes with evidence of medullary epithelial 
cell degeneration (Figure 48). Thymic corpuscles were similar to those 
of control animals.
Light Microscopy - Study IV
Tissues for microscopic evaluation were obtained from DNCB sen­
sitized animals in groups VI, V II, V II I ,  and IX. Sensitized animals were 
skin tested at time intervals of 0, 7, 14, or 21 days post-sensitization 
and the thymus collected immediately after the 72 hour reading.
Control animals. The thymus of control animals which were skin 
tested upon completion of DNCB sensitization (0 time interval) exhibited 
a marked increase in the relative proportion of small cortical lymphocytes 
(Figure 39). At low magnification (Figure 19), the cortex appeared to
36
exhibit a reduction in the number of lymphocytes but the apparent reduc­
tion in number was caused by the reduction in average cell size rather 
than to actual cell loss. The increase in small lymphocyte population 
at time interval 0 is particularly striking when the sensitized control 
animals of this group (VI-B) (Figure 39) are compared to the non-sensi- 
tized control animals in Study I I I  (Figures 33, 35, 37). The relative 
number of small cortical lymphocytes decreased as the time interval 
between skin test and last day of sensitization increased. The changes 
between the 0 and the 21 day time intervals are illustrated in Figures 
39 and 41.
The medulla and corticomedullary junctional areas exhibited no 
detectable changes.
Experimental animals. PH treated animals with cortical lympho­
cyte depletion showed evidence of lymphocyte replenishment even when 
examined immediately after completion of DNCB sensitization (0 time inter­
val) (Figures 20, 30, 40). These experimental animals (VI-A) did not 
have the extensive cortical lymphocyte replenishment of the animals exam­
ined at the 21 day interval (IX-A) (Figures 20, 22, 30, 32, 40, 42).
When the experimental animals in groups IX-A (21 day interval) were com­
pared to the corresponding control group (IX-B), the experimental animals 
showed signs of overcompensation in cortical lymphocyte production 
(Figures 21, 22, 31, 32, 41, 42).
The thymic medullary regions of experimental animals examined 
at 0, 7, 14, and 21 day intervals were indistinguishable from control 
animals (Figures 49, 50, 51, 52).
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Figure 13. Control Guinea Pig Thymus from Animal Treated with 7 Daily 
Injections of Water (Group III-B ; H&E 230X).
Figure 14. Experimental Guinea Pig Thymus from Animal Treated with 7 
Daily Injections of Procarbazine Hydrochloride (Group
III-A ; H&E 230X).
Figure 15. Control Guinea Pig Thymus from Animal Treated with 14 Daily 
Injections of Water (Group IV-B; H&E 230X).
Figure 16. Experimental Guinea Pig Thymus from Animal Treated with 14 
Daily Injections of Procarbazine Hydrochloride (Group
IV-A; H&E 230X).
Figure 17. Control Guinea Pig Thymus from Animal Treated with 21 Daily 
Injections of Water (Group V-B; H&E 230X).
Figure 18. Experimental Guinea Pig Thymus from Animal Treated with 21 
Daily Injections of Procarbazine Hydrochloride (Group V-A; 
H&E 23GX).
Figure 19. Control Guinea Pig Thymus from Animal Treated with 21 Daily 
Injections of Water and Sacrificed at 0 Day Interval Post 
DNCB Sensitization (Group VI-B; H&E 230X).
Figure 20. Experimental Guinea Pig Thymus from Animal Treated with 21 
Daily Injections of Procarbazine Hydrochloride and 
Sacrificed at 0 Day Interval Post DNCB Sensitization 
(Group VI-A; H&E 230X).
Figure 21. Control Guinea Pig Thymus from Animal Treated with 21 Daily 
Injections of Water and Sacrificed at 21 Day Interval Post 
DNCB Sensitization (Group IX-B; H&E 230X).
Figure 22. Experimental Guinea Pig Thymus from Animal Treated with 21 
Daily Injections of Procarbazine Hydrochloride and 
Sacrificed at 21 Day Interval Post DNCB Sensitization 
(Group IX-A; H&E 230X).
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Figure 23. Control Guinea Pig Thymus from Animal Treated with 7 Daily 
Injections of Water (Group III-B ; H&E 920X).
Figure 24. Experimental Guinea Pig Thymus from Animal Treated with 7 
Daily Injections of Procarbazine Hydrochloride (Group
III-A ; H&E 920X).
Figure 25. Control Guinea Pig Thymus from Animal Treated with 14 Daily 
Injections of Water (Group IV-B; H&E 920X).
Figure 26. Experimental Guinea Pig Thymus from Animal Treated with 14 
Daily Injections of Procarbazine Hydrochloride (Group
IV-A; H&E 920X).
Figure 27. Control Guinea Pig Thymus from Animal Treated with 21 Daily
Injections of Water (Group V-B; H&E 920X).
Figure 28. Experimental Guinea Pig Thymus from Animal Treated with 21
Daily Injections of Procarbazine Hydrochloride (Group
V-A; H&E 920X).
Figure 29. Control Guinea Pig Thymus from Animal Treated with 21 Daily
Injections of Water and Sacrificed at 0 Day Interval Post 
DNCB Sensitization (Group VI-B; H&E 920X).
Figure 30. Experimental Guinea Pig Thymus from Animal Treated with 21
Daily Injections of Procarbazine Hydrochloride and 
Sacrificed at 0 Day Interval Post DNCB Sensitization 
(Group VI-A; H&E 920X).
Figure 31: Control Guinea Pig Thymus from Animal Treated with 21 Daily
Injections of Water and Sacrificed at 21 Day Interval Post 
DNCB Sensitization (Group IX-B; H&E 920X).
Figure 32: Experimental Guinea Pig Thymus from Animal Treated with 21
Daily Injections of Procarbazine Hydrochloride and 
Sacrificed at 21 Day Interval Post DNCB Sensitization 











Figure 33. Control Guinea Pig Thymic Cortex from Animal Treated with
7 Daily Injections of Water (Group III-B ; H&E 2,310X).
Figure 34. Experimental Guinea Pig Thymic Cortex from Animal Treated
with 7 Daily Injections of Procarbazine Hydrochloride 
(Group III-A ; H&E 2,310X).
Figure 35. Control Guinea Pig Thymic Cortex from Animal Treated with 
14 Daily Injections of Water (Group IV-B; H&E 2,310X).
Figure 36. Experimental Guinea Pig Thymic Cortex from Animal Treated 
with 21 Daily Injections of Procarbazine Hydrochloride 
(Group IV-A; H&E 2,310X).
Figure 37. Control Guinea Pig Thymic Cortex from Animal Treated with
21 Daily Injections of Water (Group V-B; H&E 2,310X).
Figure 38. Experimental Guinea Pig Thymic Cortex from Animal Treated
with 21 Daily Injections of Procarbazine Hydrochloride 
(Group V-A; H&E 2,310X).
Figure 39. Control Guinea Pig Thymic Cortex from Animal Treated with
21 Daily Injections of Water and Sacrificed at 0 Day 
Interval Post DNCB Sensitization (Group VI-B; H&E 2,310X).
Figure 40. Experimental Guinea Pig Thymic Cortex from Animal Treated
with 21 Daily Injections of Procarbazine Hydrochloride and 
Sacrificed at 0 Day Interval Post DNCB Sensitization 
(Group VI-A; H&E 2,310X).
Figure 41. Control Guinea Pig Thymic Cortex from Animal Treated with
21 Daily Injections of Water and Sacrificed at 21 Day 
Interval Post DNCB Sensitization (Group IX-B; 2,310X).
Figure 42. Experimental Guinea Pig Thymic Cortex from Animal Treated
with 21 Daily Injections of Procarbazine Hydrochloride and 
Sacrificed at 21 Day Interval Post DNCB Sensitization 
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Figure 43. Control Guinea Pig Thymic Medulla from Animal Treated with
7 Daily Injections of Water (Group III-B ; H&E 2,310X).
Figure 44. Experimental Guinea Pig Thymic Medulla from Animal Treated
with 7 Daily Injections of Procarbazine Hydrochloride 
(Group III-A ; H&E 2,310X).
Figure 45. Control Guinea Pig Thymic Medulla from Animal Treated with 
14 Daily Injections of Water (Group IV-B; H&E 2,310X).
Figure 46. Experimental Guinea Pig Thymic Medulla from Animal Treated 
with 14 Daily Injections of Procarbazine Hydrochloride 
(Group IV-A; H&E 2,310X).
Figure 47. Control Guinea Pig Thymic Medulla from Animal Treated with
21 Daily Injections of Water (Group V-B; H&E 2,310X).
Figure 48. Experimental Guinea Pig Thymic Medulla from Animal Treated
with 21 Daily Injections of Procarbazine Hydrochloride 
(Group V-A; H&E 2,310X).
Figure 49. Control Guinea Pig Thymic Medulla from Animal Treated with
21 Daily Injections of Water and Sacrificed at 0 Day 
Interval Post DNCB Sensitization (Group VI-B; H&E 2,310X).
Figure 50. Experimental Guinea Pig Thymic Medulla from Animal Treated
with 21 Daily Injections of Procarbazine Hydrochloride and 
Sacrificed at 0 Day Interval Post DNCB Sensitization 
(Group VI-A; H&E 2,310X).
Figure 51. Control Guinea Pig Thymic Medulla from Animal Treated with
21 Daily Injections of Water and Sacrificed at 21 Day 
Interval Post DNCB Sensitization (Group IX-B; H&E 2,31QX).
Figure 52. Experimental Guinea Pig Thymic Medulla from Animal Treated
with 21 Daily Injections of Procarbazine Hydrochloride and 
Sacrificed at 21 Day Interval Post DNCB Sensitization 
(Group IX-A; H&E 2.310X).
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Electron Microscopy -  Study I I I  
Tissue for electron microscopic evaluation was obtained from 
animals in groups I I I ,  IV and V. These animals received PH or water for 
7, 14, or 21 days prior to sacrifice.
Control animals. The thymic cortex of control animals receiving 
7, 14, or 21 daily injections of water showed stellate epithelial cells 
surrounded by small, medium and large sized thymic lymphocytes (Figures 
53, 54, 55). The lymphocyte population consisted of cells in various 
stages of differentiation and contained an impressive proportion of med­
ium and large sized cortical lymphocytes (Figures 53, 54, 55). Many 
lymphocytes demonstrated short blunt cytoplasmic processes which were 
interdigitated with the perinuclear cytoplasm or with the processes of 
adjacent epithelial cells (Figures 53, 54).
Cortical thymic epithelial cells of control animals demonstrated 
the classic large vesicular nucleus with prominent nucleolus and sparse 
perinuclear cytoplasm (Figures 53, 54). The epithelial cell cytoplasm 
and peripheral cytoplasmic processes contained tonofibrils, electron 
dense bodies and membrane bound bodies (Figures 53, 54, 55). Cytoplasmic 
processes of adjacent cortical epithelial cells were joined by typical 
desmosomes (Figure 55).
Medullary regions of control animals displayed a normal arrange­
ment of thymic lymphocytes intermingled with medullary epithelial cell 
processes (Figure 56). This region also displayed normal "medullary 
squamous epithelial cells" forming thymic corpuscles (Hassall's corpus­
cles; Figure 57) as well as the more peripherally located "cystic medul­
lary epithelial" cells (Figure 56).
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Experimental animals. The thymic cortex of animals receiving 
7, 14 or 21 daily injections of PH were markedly depleted of small, 
medium and large sized lymphocytes (Figures 58, 59, 60, 61, 62, 63). After 
short term procarbazine treatment (7 days), the residual“lymphocytes dem­
onstrated nuclear chromatin patterns which were similar to those of con­
trol animals (Figures 53, 54, 55, 58, 59, 60, 61, 62, 63). With longer 
treatment (14 or 21 days), the cortical thymic lymphocytes exhibited 
varying degrees of cell injury, but overtly necrotic lymphocytes were not 
seen. Specific alterations in the residual lymphocyte population includ­
ed nuclear polymorphism (Figures 60, 61) and cytoplasmic hypertrophy 
(Figures 60 and 61). The damaged lymphocytes exhibited morphological 
evidence of phagocytosis with the accumulation of intracytoplasmic debris 
(lamellar and amorphous electron dense material; Figures 58, 60). Tightly 
interlocked cytoplasmic processes (Figure 59) were occasionally demon­
strated between the residual cortical lymphocytes.
Cortical epithelial cells of animals receiving PH were highly 
altered. These cellular changes appeared with short exposure (7 days) 
and became more severe with prolonged treatment. The nuclear changes 
were less dramatic than cytoplasmic changes and consisted of a progressive 
polymorphism in nuclear morphology without significant changes in the 
nuclear chromatin pattern (Figures 58, 60, 61, 62). The cytoplasmic re­
gions of cortical epithelial cells from animals treated with 7, 14 or 21 
injections of PH demonstrated marked degrees of cell injury and cytoplas­
mic degeneration. The perinuclear cytoplasm and peripheral cytoplasmic 
processes were greatly enlarged and contained an increased number of intra­
cytoplasmic structures (Figures 58, 60, 61, 62, 63). These cytoplasmic
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structures consisted of dense and membrane bound bodies and vacuoles 
with and without granular material (Figures 58, 59, 60, 61, 62, 63).
The epithelial cells of animals treated with 14 daily injections of PH 
displayed the most severe degree of cellular injury (Figures 60, 61,
62) and exhibited polymorphonuclear leukocyte infiltration. These in­
filtrating  cells were found within the cytoplasm of damaged epithelial 
cells (Figures 61, 62). After 21 daily injections of PH, macrophages 
could also be demonstrated within the thymus cortex (Figure 63). Macro­
phages were located within the subcapsular areas and displayed evidence 
of intracytoplasmic lysosomal-like bodies but macrophages were never 
demonstrated inside the damaged epithelial cells.
Animals treated with 7 daily injections of PH demonstrated slight 
ultrastructural alteration of their medullary lymphocytes (Figures 56, 57, 
64, 65). The medullary lymphocytes in animals treated with PH for 14 days 
demonstrated morphological alterations similar to those noted in the cor­
tex (Figures 60, 61, 62, 66).
The medullary epithelial cells in animals treated with 7 daily 
injections of PH demonstrated minor degrees of nuclear and cytoplasmic 
alteration (Figures 64, 65). Changes in the nuclear architecture and 
chromatin pattern of medullary epithelial cells were unremarkable (Figures 
64, 65) but the cytoplasmic regions displayed increased amounts of rough 
endoplasmic reticulum and lip id vacuoles (Figure 64). The thymic medul­
lary epithelial cells in animals treated with 14 daily injections of PH 
demonstrated morphological alterations similar to those noted in the 
cortex (Figures 60, 61, 62, 66).
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Electron Microscopy - Study IV
Tissue for electron microscopic evaluation was obtained from 
DNCB sensitized experimental and control animals in groups VI, V II, V III 
and IX. Sensitized animals were skin tested at time intervals of 0, 7,
14 or 21 days post-sensitization and the thymus collected immediately 
after the 72 hour reading.
Control animals. Ultrastructural examination of thymus tissues 
from control animals sacrificed at 0 and 21 day intervals post-sensiti­
zation demonstrated a predominance of small cortical lymphocytes (Figures 
67, 68). The electron microscopic characteristics of the cortical lymph­
ocytes and epithelial cells were similar to those listed for control 
animals in Study I I I  (Figures 53, 54, 55, 67, 68).
The ultrastructural characteristics of the medullary lymphocytes 
and epithelial cells were similar to those listed for control animals in 
Study I I I .
Experimental animals. Electron microscopic examination of cor­
tical thymic lymphocytes from PH treated animals sacrificed at 0 and 21 
day intervals after completion of DNCB sensitization revealed a mixture 
of small, medium and large sized lymphocytes (Figures 69, 70). Although 
there was a slight predominance of medium and large sized cells, the 
nuclear and cytoplasmic characteristics of these lymphocytes were unre­
markable.
Thymic cortical epithelial cells from animals sacrificed at 0 
day interval post-sensitization were similar in ultrastructural changes 
to those of animals in Study I I I  treated with either 14 or 21 daily 
injections of PH (Figures 60, 61, 62, 69). Cortical epithelial cells in
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animals sacrificed 21 days post-sensitization were indistinguishable from 
those of corresponding control groups (Figures 68, 70).
Thymic medullary lymphocytes, epithelial cells and thymic cor­
puscles (Hassall's corpuscles) were unaltered morphologically.
50
Figure 53. Control Animal, Study I I I :  Thymic cortex of guinea pig 
treated with 14 daily injections of water. The cortical 
epithelial cells (E) exhibit a large vesicular nucleus 
(N) with a delicate layer of marginal chromatin and a 
prominent nucleolus. The epithelial cells have a thin 
rim of electron-lucent perinuclear cytoplasm with long 
processes (P) which extend into the surrounding popula­
tion of thymic lymphocytes. The lymphocyte population 
consists of cells in various stages of differentiation 
and consists primarily of small (S) and medium (M) sized 







Figure 54. Control Animal, Study I I I :  Thymic cortex of guinea pig 
treated with 14 daily Injections of water. The thymus 
cortex contains epithelial cells (E) surrounded by a mix­
ture of small (S), medium (M) and large (L) sized lympho­
cytes. The perinuclear cytoplasm of the cortical epithe­
lia l cell shows two short blunt cytoplasmic processes (*) 
extending from the adjacent large Ijmiphocyte. (uranyl 









Figure 55. Control Animal, Study I I I :  Thymic cortex of guinea pig 
treated with 14 daily injections of water. The cortical 
thymic epithelial cell processes (P) contain a few cyto­
plasmic structures, e.g., electron dense bodies (+), 
membrane bound bodies , and are attached to the peri­
pheral processes of adjacent epithelial cells by typical 
desmosomes (D). The normal population of small (S), 
medium (M) and large (L) sized thymic lymphocytes are 
easily detected between the peripheral processes of the 





Figure 56. Control Animal, Study I I I :  Thymic medulla of guinea pig 
treated with 14 daily injections of water. A cystic 
medullary epithelial cell (E) and a typical population 
of medullary lymphocytes are shown. Note the difference 
in cytoplasmic density of the medullary lymphocyte pop­





Figure 57. Control Animals, Study I I I :  Thymic medulla of guinea pig 
treated with 14 daily injections of water. The medullary 
region exhibits a Hassall's corpuscle (H) containing 
intra-corpuscular debris (D) surrounded by squamous epi­
thelial cells (S). A representative population of medul­
lary lymphocytes (L) appear at the periphery of the 






Figure 58. Experimental Animal, Study I I I :  Thymic cortex of guinea 
pig treated with 7 daily injections of procarbazine 
hydrochloride. The cortex exhibits a marked depletion of 
thymic lymphocytes. The residual population consists of 
only a few small (S) and medium (M) sized cortical lymph­
ocytes. A damaged medium sized lymphocyte exhibits mor­
phological evidence suggesting phagocytosis of lamellar 
debris (LD). Cortical epithelial cells (E) demonstrate 
evidence of degeneration. Perinuclear cytoplasm and 
cytoplasmic processes of the epithelial cells are greatly 
enlarged, exhibit tonofilaments W  and contain increased 
numbers of electron dense bodies (ED) and membrane bound 








Figure 59. Experimental Animal, Study I I I ;  Thymic cortex of guinea 
pig treated with 7 daily injections of procarbazine hydro­
chloride. In other areas, the cortex exhibits a depletion 
of thymic lymphocytes, but this area of the depleted cor­
tex shows a representative group of the residual lympho­
cyte population (L). An interlocking cytoplasmic process 
(-»■) can be seen between two of the residual lymphocytes. 
Epithelial cell processes (C) are enlarged and contain 
increased numbers of abnormal structures, (uranyl acetate 
and lead citrate 8,100X).
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Figure 60. Experimental Animal, Study I I I :  Thymic cortex of guinea 
pig treated with 14 daily injections of procarbazine 
hydrochloride. The cortex exhibits marked cellular deple­
tion. Residual cortical lymphocytes exhibit varying 
degrees of cell injury but overtly necrotic cells are not 
seen. Specific alterations include slight nuclear changes 
and the accumulation of intracytoplasmic amorphous debris 
(^) which suggests phagocytic activity. The cortical epi­
thelial cells (E) display evidence of degeneration. De­
generative changes consist of cytoplasmic hypertrophy 
with the appearance of increased numbers of abnormal 
structures, ê .c[., membrane bound bodies (MG), electron 
dense bodies (ED) and cystic vacuoles with or without 
granular material (C). (uranyl acetate and lead citrate 
6,210X).
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Figure 61. Experimental Animal, Study I I I :  Thymic cortex of guinea 
pig treated with 14 daily injections of procarbazine 
hydrochloride. The thymic cortex exhibits evidence of 
marked 1mphocytic depletion. The few remaining lympho­
cytes (L) demonstrate nuclear polymorphism (P) and cyto­
plasmic expansion (C). The cortical epithelial cells (E) 
exhibit less dramatic alterations in nuclear morphology 
than the residual lymphocytes. The cytoplasmic regions 
of the cortical epithelial cells show marked degenerative 
changes. This micrograph shows a polymorphonuclear leuk­
ocyte (G) located within the degenerating cytoplasm of a 











Figure 62. Experimental Animal, Study I I I :  Thymic cortex of guinea 
pig treated with 14 daily injections of procarbazine 
hydrochloride. The cortex exhibits marked lymphocytic 
depletion and severe derangement. The few residual lymph­
ocytes (L) demonstrate evidence of cellular damage. The 
cortical epithelial cells (E) demonstrate nuclear poly­
morphism and contain increased numbers of electron dense 
bodies (ED), membrane bound bodies (MB) and vesicular 
cysts. Polymorphonuclear leukocytes (G) are seen within 
the degenerating epithelial cell cytoplasm, (uranyl 
acetate and lead citrate 5,750X).
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Figure 63. Experimental Animal, Study I I I :  Thymic subcapsular re­
gion of guinea pig treated with 21 daily injections of 
procarbazine hydrochloride. The subcapsular region shows 
marked depletion of cortical lymphocytes. The remaining 
lymphocytes (L) demonstrate increased nuclear density.
The epithelial cell (E) cytoplasmic processes (P) are 
greatly expanded and contain electron dense bodies (ED), 
membrane bound bodies (MB), lipid vacuoles (8), tono- 
filaments (-»■) and are connected to adjacent epithelial 
cells by desmosomes (D). The macrophages (M) demonstrate 
an abundance of lysosomal-like bodies, (uranyl acetate 
and lead citrate 6,440X).
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Figure 64. Experimental Animal, Study I I I :  Thymic medulla of guinea 
pig treated with 7 daily injections of procarbazine hydro­
chloride. The medullary lymphocytes (l) exhibit slight 
morphological alteration. One medullary epithelial cell 
(E) shows an abundance of rough endoplasmic reticulum (ER) 
with distended mitochondria (M) and lipid vacuoles (*). 
This micrograph shows increased intercellular spaces and 
the presence of a polymorphonuclear leukocyte (G) in the 
cleft (H) of the Hassall's corpuscle, (uranyl acetate 
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Figure 65. Experimental Animal, Study I I I :  Thymic medulla of guinea 
pig treated with 7 daily injections of procarbazine hydro­
chloride. The medullary lymphocytes (L) do not show 
signs of morphological alteration. Villous medullar epi­
thelial cells (E) display numerous microvilli projecting 
into the adjacent cleft (H) of Hassall's corpuscle. The 
peripheral processes (P) of the medullary epithelial cells 
contain an abundance of small intracytoplasmic vesicles 




Figure 66. Experimental Animal, Study I I I :  Thymic medulla of guinea 
pig treated with 14 daily injections of procarbazine 
hydrochloride. This micrograph demonstrates marked deple­
tion of medullary lymphocytes. The remaining lymphocytes 
(L) are moderately altered and show signs of nuclear poly­
morphism. The medullary epithelial cell (E) cytoplasmic 
regions (C) are greatly enlarged but remain connected to 
adjacent epithelial cells by desmosomes (D). This repre­
sentative area shows cellular debris (•>) and the presence 







Figure 67. Control Animal, Study IV; Thymie cortex of control guinea 
pig sacrificed at 0 day interval post DNCB sensitization. 
This micrograph shows an abundance of small (3) and medium 
(M) sized cortical lymphocytes. The cortical epithelial 
cells (E) exhibit large vesicular nuclei (N) with long 
thin cytoplasmic processes (P). Processes are dispersed 
between adjacent lymphocytes and are connected to other 
epithelial cell processes by desmosomes (D). (uranyl 






Figure 68. Control Animal, Study IV: Thymie cortex of control guinea 
pig sacrificed at 21 day interval post DNCB sensitization. 
The thymic cortex contains a large number of small corti­
cal lymphocytes (S). The lymphocytes are clustered between 
the long thin epithelial cell (E) processes (P). These 
processes contain a few intracytoplasmic organelles, e .£ ., 
mitochondria (M), and electron dense bodies (ED), (uranyl 





Figure 69. Experimental Animal, Study IV: Thymie cortex of a pro­
carbazine hydrochloride treated guinea pig sacrificed 
at 0 day interval post DNCB sensitization. The cortical 
region shows a mixture of small (S), medium (M), and 
large (L) sized lymphocytes. The nucleus and cytoplasm 
of these cells are morphologically unaltered. The epi­
thelial cell cytoplasmic processes (P) are expanded and 
exhibit signs of morphological damage, (uranyl acetate 
and lead citrate 7,200X).
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Figure 70. Experimental Animal, Study IV: Thymic cortex of procar­
bazine hydrochloride treated guinea pig sacrificed at 
21 day interval post DNCB sensitization. The micrograph 
shows a mixture of small (S), medium (M), and large (L) 
sized cortical lymphocytes. The recovering thymic cortex 
displays an impressive number of large and medium sized 
lymphocytes. The epithelial cell cytoplasmic processes 
are comparable in appearance to those of control animals, 
thin, non-distended, few intracytoplasmic structures. 
Typical desmosomes (D) connect adjacent epithelial cell 
processes, (uranyl acetate and lead citrate 7,200X).
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Procarbazine hydrochloride (PH), a methylhydrazine derivative, 
has been reported to induce varying degrees of toxicity in different 
animal species (15, 30, 57, 74, 77, 85). This toxicity may present as 
alopecia, anemia, weight loss, respiratory distress or lethargy. In cases 
of exceeded maximum tolerated dosage or prolonged treatment with a to l­
erated dosage, the toxicity may induce animal death (8, 57).
Maximum Tolerated Dose Level
Experimentally, a maximum tolerated dosage of PH was set at a 
level which induced significant immunosuppression without inducing a le­
thality exceeding 20 to 25%. Maximum tolerated doses of PH appear to 
differ for each animal species (57, 85), but a pattern is presented in 
which maximum tolerated dosage levels for different species tend to 
decrease in quantity as the whole body weight of the animal increases. 
Stewart and Bell (85) reported a comparative study demonstrating maximum 
tolerated PH doses for mice, rats, and rabbits to be 120, 35, and 7.5 
mg/Kg respectively. MacDonald, et , (57) in a discussion of Scharer's 
(82) unpublished work, noted that dogs treated with 10 or 15 mg/Kg doses 
of PH experienced severe toxic effects and that prolonged treatment with 
a dosage of 5 mg/Kg of PH would induce severe toxicity. These investi-
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gâtions established the importance of toxicity due to dosage and/or dur­
ation of PH treatment for different animal species.
Since the tolerated dosage level of PH treatment for guinea 
pigs was unknown, Study I was designed to obtain this information. Uti­
lizing data obtained by previous investigators (57, 85) on mice, rats, 
rabbits, and dogs. Study I incorporated PH dosage levels of 15, 35, and 
55 mg/Kg. Following chronic treatment (21 days) with these three doses, 
i t  was noted that guinea pigs, like dogs (57), had a narrow effective 
dose range. Guinea pigs treated with the two larger doses of PH either 
died during pregraft anesthesization (55 mg/Kg), or experienced unaccep­
table levels of toxicity (35 mg/Kg) while those animals receiving the 
lowest dosage of PH (15 mg/Kg) were free from signs of toxicity. The 
absence of toxic signs suggested that 15 mg/Kg was below the effective 
immunosuppressive level.
Mice and nonhuman primates treated with PH have been reported to 
exhibit severe degrees of physiological stress or death upon anesthesi­
zation with pentobarbitol (42, 76). This sensitivity was demonstrated 
during anesthesization for skin grafting in guinea pigs receiving chronic 
PH treatment with dosage levels of 35 and 55 mg/Kg. Since skin homografts 
were performed to evaluate the degree of immunosuppression in PH treated 
guinea pigs, the pentobarbitol sensitivity required an alternative method 
for evaluating cell-mediated immune suppression.
Immunosuppressive Dose Levels 
I t  has been reported that the cellular in filtra te  of first-set 
homograft rejections (83, 91, 92, 93) is comparable to that of DNCB sen­
sitized skin test sites (28, 91). Skin sensitization with DNCB is a
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method utilized for evaluating degrees of cell-mediated immunity in cancer 
patients undergoing chemotherapeutic treatment (14, 46). Considering 
the effects of anesthesization of PH treated animals, the similarity 
between cellular infiltrates of homografts and DNCB skin test reactivity, 
and the relevance of DNCB as a means of evaluating cell-mediated immunity 
in cancer patients, skin testing using the immunogen DNCB was substituted 
for skin grafting as a means for evaluating the degree of immunosuppres­
sion.
In Study I I ,  guinea pigs were treated with an intermediate dosage 
of 25 mg/Kg to determine i f  this quantity of PH would induce immunosuppres­
sion to DNCB sensitization without exceeding a lethality of 20%. Following 
prolonged treatment (21 daily, plus 6 supplemental injections) these 
animals displayed marked immunosuppression to DNCB skin sensitization 
with minimal toxic effects. The minimal degrees of toxicity noted in 
these animals presented as retarded weight gain and mild signs of anemia. 
Although a pre-set maximum tolerated dosage with a lethality of 20% was 
not experienced in Study I I ,  the available evidence, indicating a narrow 
dose range in other species (57, 85) and the data from Study I ,  indicated 
that the dosage level for guinea pigs should not exceed 25 mg/Kg.
Toxic Effects
Hematopoietic Changes
High dosage levels or prolonged exposure to PH treatment may 
induce toxic anemia. Methylhydrazine derivatives have been reported to 
induce anemia by hemolysis of erythrocytes (30). MacDonald, et , (57) 
reported that prolonged treatment with a methylhydrazine derivative
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(procarbazine hydrochloride) induced anemia in dogs by bone marrow depres­
sion. Floersheim and Brune (30) reported a 20% decrease in erythrocyte 
count in mice treated for prolonged periods with 120 mg/Kg of PH, and a 
more severe decrease when treated with 4 daily injections at a dose level 
of 360 mg/Kg. Quagliata, et £ [ . ,  (77) reported a less severe decrease 
(10%) in erythrocyte count in rats treated for 20 days at PH dosage 
levels of 30 mg/Kg. Possanza and Stewart (74) reported physical signs 
of anemia in rats treated with 35 mg/Kg/day for 21 days followed by 17.5 
mg/Kg/day for 13 days. Physical signs of anemia (paleness of ears and 
eyes) were also demonstrated in guinea pigs receiving 21 daily injections 
of PH at dosage levels of 35 and 55 mg/Kg. Few experimental animals 
injected with the intermediate dosage of PH (25 mg/Kg) developed toxic 
anemia, and guinea pigs receiving 15 mg/Kg of PH did not demonstrate evi­
dence of anemia. Animals developing anemia in the early stages of treat­
ment almost invariably died prior to termination of treatment; however, 
i f  toxic anemia developed during the latter stages of treatment, the 
animals usually recovered after completion of treatment. Although direct 
blood studies were not performed to quantitate hematological alterations, 
indirect evidence indicated increased destruction of erythrocytes (increas­
ed hemosiderin in lungs and spleen) and increased extramedullary hemato- 
poiesis (spleen).
Weight Changes
Procarbazine hydrochloride toxicity has been reported to induce 
animal weight loss (30, 77). The degree and rate of weight loss depends 
upon the animal species and dosage of PH given. Floersheim and Brune (30) 
reported a gradual weight loss (10%) in mice receiving 120 mg/Kg of PH
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every other day for 23 days. However, they noted a precipitous weight 
loss (20%) in mice receiving 4 daily injections of 360 mg/Kg. Quagliata, 
et al .̂, (77) reported in itia l weight loss of 19% in rats receiving 30 mg/ 
Kg/day for 20 days. In both studies (30, 77), the treated animals re­
gained weight upon termination of PH treatment.
Guinea pigs treated with large doses (35 and 55 mg/Kg) of PH 
experienced a severe weight loss which was similar to the effects of 
massive PH treatment in rats (30). Experimental animals receiving an 
intermediate (25 mg/Kg) or lower dosage (15 mg/Kg) of PH exhibited retard­
ed weight gain as contrasted to severe weight loss induced by larger doses. 
The three exceptions in which experimental animals exhibited in itia l 
weight losses, noted after 7 days of PH treatment, followed thereafter by 
continuous weight gain may be attributed to early adjustments to drug 
toxicity (77) and/or to changes in their physical environment (repeated 
handling).
Respiratory Effects
Pulmonary alterations have been noted in patients receiving PH 
as a chemotherapeutic agent (21, 47, 55). Some of these alterations con­
sist of pulmonary hypersensitivity, alveolitis, pleural effusion and 
pneumonitis. Physical signs of respiratory distress were noted in some 
guinea pigs receiving PH treatment but symptoms usually developed in 
animals receiving the larger doses (35 and 55 mg/Kg) or intermediate dos­
age (25 mg/Kg) of PH for prolonged periods of time.
Mortality
Studies involving mice treated with a maximum tolerated dosage 
of PH (30) gave an animal mortality of 22.8%. A 15% mortality was exper­
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ienced in guinea pigs treated for prolonged periods of time with a dosage 
of 25 mg/Kg of PH. Of this 15%, the majority of animal deaths (66.6%) 
occurred in animals receiving the longest duration of treatment (21 daily, 
plus 6 supplemental injections).
Evaluation of Immunity
The skin sensitizing potential of DNCB in guinea pigs (23, 24,
28, 91) was substantiated in Study IV. This epidermally bound hapten 
(23, 24) was able to induce skin sensitivity to DNCB within 7 days after 
initiation of sensitization; the time interval required for sensitization 
was comparable to that reported by previous investigators (23, 24, 28, 90). 
The cell-mediated immunity demonstrated by skin testing at 24 and 48 
hours (maximal development of erythema, induration, epidermal-dermal mono­
nuclear cell in filtration) also correlated well with previous reports 
(28, 34, 91).
The effectiveness of PH treatment in suppressing the immune 
response before immunization has been demonstrated previously in experi­
mental models of transplantation and adjuvant-induced autoimmune diseases 
in mice, rats, and rabbits (15, 74, 77, 85, 86). These findings have 
been reconfirmed in the present study and extended to include another 
experimental animal. Guinea pigs receiving 21 daily treatments of PH 
prior to DNCB sensitization and supplemental PH treatment during sensiti­
zation displayed marked degrees of cell-mediated immunosuppression. 
Depending upon the method used to evaluate the skin tests, the maximum 
degrees of suppression presented at various time intervals after comple­
tion of DNCB sensitization. The maximum immunosuppression was demonstrat­
ed at 0 time interval when evaluated by test site diameter, at 7 days post-
92
sensitization when evaluated by cellular infiltration and at 14 days 
post-sensitization when evaluated by degree of induration. The degrees 
of immunosuppression decreased with discontinuation of PH treatment 
except when using induration as the means of skin test evaluation.
Procarbazine hydrochloride has been reported to suppress or 
completely abolish thymus-dependent but not thymus-independent immunity 
in rats (57, 77) and mice (29, 86). The severe lymphopenia exhibited in 
these models (30, 57, 77) has been attributed to the lymphotoxic effects 
of PH. Quagliata, et , (77) proposed that PH treatment would induce 
destruction of the thymus and thymus-dependent areas of peripheral lymph­
oid organs and demonstrated, light microscopically, cortical thymic lym­
phocyte depletion in rats treated with 20 daily injections of 30 mg/Kg 
of PH. Floersheim, et ^ . , (32) demonstrated a severe depletion of 
cortical and medullary thymic lymphocytes in adult mice following 14 in­
jections of a methyl hydrazine derivative, Ro-4-6824 (100 mg/Kg), given 
every other day over a 28 day period. These data prompted Study I I  which 
was designed to examine sequential histological changes in the thymus of 
PH treated guinea pigs. The morphological changes were followed by light 
and electron microscopy.
Study I I I  - Thymic Morphology During PH Treatment
Control Animals: Light and Electron Microscopy
Light and electron microscopic characteristics of the thymus 
glands from untreated guinea pigs of Study I I I  were similar in morphology 
to those reported previously for mice, rats, and guinea pigs (1, 45, 49, 
59, 60, 79).
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Experimental Animals: Light Microscopy 
Light microscopic examination of thymic tissue from guinea pigs 
treated with 7, 14, or 21 daily injections of PH substantiated the ear­
lie r reports on rats (77) and mice (32) by inducing a marked depletion 
of small, medium and large sized cortical lymphocytes. Although Quagliata, 
et , (77) did not make specific reference to medullary lymphocyte 
depletion in the rat, Floersheim, et , (32) detected medullary deple­
tion in mice.
In the present study, guinea pigs receiving 7 and 14 daily in­
jections of PH did not demonstrate marked medullary lymphocyte depletion. 
However, animals receiving 21 daily injections of PH did demonstrate a 
slight degree of medullary lymphocytic depletion. The differences be­
tween the thymic medullary changes in this study and in those of Floersheim, 
et al^., (32) could be attributed either to a chemical difference in the 
methyl hydrazine derivative utilized or to biological differences in the 
experimental animals.
Experimental Animals: Electron Microscopy 
Cortical lymphocytes. Cowan and Sorenson (17), Malacarne and 
Castaldi (58), Abe and Ito (1), Hauk, et , (41), and Gad and Clark 
(33) reported rapid severe depletion of cortical lymphocytes in adult 
mice and rats treated with the immunosuppressive drugs, hydrocortisone 
and cyclophosphamide, and with the stress-producing agent, endotoxin. 
Ultrastructural examination of the hydrocortisone and endotoxin treated 
mice indicated that the firs t significant evidence of damage occurred in 
the lymphocyte nuclei. The nuclear changes involved progressive chroma­
tin condensation with the formation of pycnotic nuclei followed by death
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(17, 33). Although the ultimate fate of the damaged lymphocytes was 
lysis, the early cytoplasmic alterations were reported to be minimal in 
the hydrocortisone treated mice (17). Cowan and Sorenson (17) stated 
that the depletion elicited by hydrocortisone treatment involved pri­
marily the small cortical thymic lymphocytes and that maximal thymic in­
volution occurred 2 days after the second of two consecutive injections 
of hydrocortisone given at 24 hour intervals, i.e .., 3 days. At the time 
of maximal hydrocortisone response (3 days), the involuting thymic cortex 
contained only a few small thymic lymphocytes.
Electron microscopic examination of thymic tissue from guinea 
pigs treated with 7, 14, or 21 daily injections of PH also demonstrated 
severe cortical lymphocyte depletion but the PH-induced depletion involv­
ed equally the small, medium and large sized lymphocytes. Nuclear changes 
comparable to those described for hydrocortisone treated mice were not 
seen in the thymus of PH treated guinea pigs at any time interval exam­
ined. The cytoplasm of the residual cortical lymphocytes demonstrated 
only moderate evidence of cell injury even after 21 daily PH treatments. 
Occasionally, tightly interlocked cytoplasmic processes were noted be­
tween residual lymphocytes in PH treated guinea pigs, but the direct cyto­
plasmic communications described by Balboni (3) during cortisone-induced 
thymic involution in rats could not be demonstrated.
The demonstration of severe cortical lymphocyte depletion in 
PH treated guinea pigs with minimal evidence of intrathymic lymphocyte 
destruction was an unexpected finding. This apparent discrepency could 
possibly be explained by the length of time between the initiation of PH 
treatment and the firs t tissue collection (7 days) but this would require
95
almost immediate destruction and precipitous removal of all traces of 
cellular debris. Furthermore, phagocytic cells, polymorphonuclear leuco­
cytes and macrophages, did not appear until the 14 day sample when the 
epithelial components exhibited the most severe damage. The actual cause 
for this discrepency can not be given at this time, but indirect evidence 
suggests a mass exodus of almost all cortical lymphocytes rather than 
destruction in situ. The persistence of a small residual lymphocyte pop­
ulation in the cortex of PH treated guinea pigs may be attributed to the 
proposed heterogeneity of the cortical lymphocyte population. Abe and 
Ito (1) proposed that approximately 5 %  of the cortical lymphocytes are 
medullary in nature both morphologically and functionally (long-lived).
I t  may be significant that these residual lymphocytes did not begin to 
exhibit significant morphological changes until approximately 14 days of 
treatment when the cortical epithelial cell damage was most severe.
Medullary lymphocytes. Abe and Ito (1) reported in their ultra- 
structural study of hydrocortisone treated mice that the small medullary 
lymphocytes of experimental animals were comparable to those of untreated 
controls. Electron microscopic examination of medullary lymphocytes in 
guinea pigs treated with 7 daily injections of PH were unremarkable when 
compared to controls, but animals receiving 14 daily injections of PH did 
demonstrate minor degrees of medullary lymphocyte alteration.
The absence of early medullary lymphocyte alterations could be 
attributed to the postulated heterogeneity of the thymic lymphocyte pop­
ulation with a corresponding difference in drug sensitivity. Abe and Ito 
(1) have proposed that short-lived thymic lymphocytes have their residency 
within the cortex, whereas the long-lived cells may reside within the
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medullary region. The observation that prolonged PH treatment is neces­
sary to produce alterations in the population of medullary lymphocytes 
of guinea pigs may lend some support to their hypothesis since the medul­
lary and residual cortical lymphocyte populations begin to show signifi­
cant changes at the same time. I t  is tempting to speculate that the 
residual cortical lymphocyte population is medullary in nature and is 
indeed long-lived.
Cortical epithelial cells. Cowan and Sorenson (17) were unable 
to detect significant ultrastructural changes in the cortical epithelial 
cells of mice 24 hours after hydrocortisone injection. After a longer 
time period (3 days post-injection), they were able to demonstrate dis­
tinct ultrastructural alterations in the cortical epithelial cells. These 
alterations consisted of many small intracytoplasmic vesicles or of fewer 
large cystic vesicles. The cortical epithelial cell alterations noted in 
guinea pigs treated with 7, 14, or 21 daily injections of PH consisted of 
cytoplasmic hypertrophy, increased numbers of electron dense bodies, 
membrane bound bodies, cystic vesicles with or without intracystic gran­
ular material, and degeneration. I t  was noted that the most severely 
damaged cortical epithelial cells were found in animals treated with 14 
daily injections of PH. I t  may be significant that the time of maximal 
epithelial cell damage coincided with the previously discussed changes 
in the residual cortical lymphocyte population and with the appearance 
of phagocytic cells.
Medullary epithelial cells. Although guinea pigs treated with 
7 daily injections of PH did not demonstrate ultrastructural alteration 
of the medullary epithelial cells, animals injected with 14 daily injec­
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tions of PH did demonstrate medullary epithelial cell alterations. These 
alterations were similar to the cortical epithelial cell degeneration 
noted in animals receiving 14 daily injections.
Cortical invasive cells. Castaldi, et £I_., (13) and Harris and 
Kugler (40) demonstrated the migration of granular leucocytes into the 
thymic cortex of mice and guinea pigs following treatment with cyclophos­
phamides or with rabbit anti-guinea pig thymus serum. Both groups (13,
40) fe lt  that the purpose of the invading granulocytes was to phagocytize 
cellular debris. Cowan and Sorenson (17) reported the presence of leuco­
cytes 4 days following the second injection in their hydrocortisone 
treated mice and described the invading leucocytes as being located in 
"—large thymic epithelial cell cysts".
Guinea pigs treated with 14 daily injections of PH also exhibited 
polymorphonuclear leucocytes within the cytoplasm of degenerating corti­
cal epithelial cells. Despite their intracellular position and proximity 
to cortical epithelial cell debris, the leucocytes did not demonstrate 
marked morphological evidence of phagocytosis. The subcapsular macro­
phages which appeared in animals receiving 21 daily injections of PH did 
exhibit evidence of phagocytosis (lysosomal-like bodies). Although ac­
tual ingestion was not demonstrated for either the polymorphonuclear 
leucocytes or for the macrophages, i t  would be appropriate to suggest 
that their presence was stimulated by degenerating cells and that their 
function was to ingest such material.
Study IV - Thymic Morphology During Recovery from PH Treatment
Light and electron microscopic examination of thymus tissue from 
sensitized controls and sensitized PH treated guinea pigs revealed the
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presence of small, medium and large sized cortical lymphocytes. The 
sensitized control animals demonstrated an increased proportion of small 
cortical lymphocytes when compared to the unsensitized control animals 
in Study I I I .  The role of the thymus in cell-mediated immunity (63) and 
the evidence that DNCB stimulated a strong cel1-mediated immune response 
in guinea pigs (28, 91) may have had an important influence on the small 
lymphocyte population noted in DNCB sensitized control animals. To dem­
onstrate a more accurate immunogenic influence upon mature differentiation 
of thymic lymphocytes will require additional study.
By indirect observation, the greatest degree of thymic cortex 
cellularity correlated with the time of strongest skin test activity to 
DNCB sensitization. Sensitized control animals skin tested at 0 day in­
terval post-sensitization and sacrificed 72 hours later demonstrated a 
more cellular thymic cortex than did sensitized control animals sacrificed 
21 days post-sensitization. These control animals also demonstrated the 
strongest skin test response to DNCB sensitization as indicated by skin 
test diameters and degrees of mononuclear cell infiltration. The over 
all cellularity of the thymic cortex was greater in sensitized control 
animals sacrificed at 0 day interval post-sensitization than in sensitized 
control animals sacrificed 21 days post-sensitization. The actual propor­
tion of small cortical thymic lymphocytes may have been larger in animals 
sacrificed at the later time interval. When evaluating thymic recovery 
in the PH treated animals, consideration must be given both to the role 
of antigenic stimulation and to the natural lymphocyte replenishment 
upon cessation of treatment.
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Quagliata, e t ^ . , (77) demonstrated, light microscopically, 
that rats treated with 100 mg/Kg of a methylhydrazine derivative (Ro-4- 
6824) replenished the cortical and medullary regions of the thymus within 
18 days after cessation of drug treatment. In mice, Cowan and Sorenson 
(17) reported an increase in the number of thymic epithelial cells and a 
reappearance of thymic lymphocytes (predominantly large lymphocytes) with­
in 6 days following the last injection of hydrocortisone. Twelve days 
following the last injection of hydrocortisone, the mouse thymus was nor­
mal (17).
Light and electron microscopic examination of the thymus from 
guinea pigs receiving 21 daily injections of PH followed by DNCB sensi­
tization and sacrifice at 0 day interval post-sensitization revealed 
replenishment of small, medium and large sized lymphocytes. The early 
lymphocytic replenishment of PH treated, DNCB sensitized animals in this 
study can not be compared directly to the work of Quagliata, et ^ . ,
(77) or Cowan and Sorenson (17) because the animals were undergoing DNCB 
sensitization and were also receiving supplemental PH treatment during 
the 7 days in which lymphocyte replenishment occurred. Direct correla­
tion of the rate of thymic replenishment in guinea pigs with the earlier 
studies of rats (77) and mice (17) would have required the use of PH 
treated animals without verified immunosuppression.
Central and Peripheral Lymphoid Interaction
The role of the thymus as a central lymphoid organ (63, 71) and 
its role in the development of peripheral lymphoid tissue has received 
a considerable amount of attention. Emigration of lymphoid cells from 
the thymus to peripheral lymphoid organs has been demonstrated in the
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guinea pig (53, 54, 65, 67, 68). Linna (53) has reported that with DNCB 
stimulation of cell-mediated immunity in guinea pigs there is a change 
in thymus cell migration patterns to favor the lymph nodes within the 
areas of sensitization. He further emphasized that there is no increased 
proliferation of thymus lymphocytes, i_.ê ., proliferation is confined 
primarily to the peripheral lymphoid tissues.
Unpublished observations on peripheral lymph nodes from DNCB 
sensitized guinea pigs in this stucly substantiate these observations of 
Linna (53). In DNCB sensitized guinea pigs, there was not a marked in­
crease in the number of cortical thymic lymphocytes undergoing mitosis; 
however, the earliest thymic tissue removed from DNCB sensitized animals 
was 10 days following their f irs t exposure to DNCB. This 10 day lag is 
probably too long to detect an increase in thymic lymphocytic mitoses.
The overcompensation with small cortical lymphocytes in animals which 
were previously depleted of cortical lymphocytes prior to DNCB sensiti­
zation stimulates questions concerning the possible role of antigen 
stimulation on thymic lymphocyte proliferation.
Cowan and Sorenson (17) described an increase in thymic epithe­
lia l cells of mice 6 days after completion of hydrocortisone treatment. 
Electron microscopic examination of thymic tissue from PH treated guinea 
pigs sacrificed at 0 day interval post-sensitization demonstrated highly 
altered cortical thymic epithelial cells. These differences in epithe­
lia l cell morphology may be related to the fact that the animals in this 
study received supplemental PH injections to within 3 days of sacrifice.
CHAPTER V 
SUMMARY AND CONCLUSIONS
The objectives of this study were: 1) to determine an effective
immunosuppressive dose level of procarbazine hydrochloride (PH) for guinea 
pigs; 2) to demonstrate by light and electron microscopy the sequential 
changes in guinea pig thymus during PH treatment; 3) to compare the sever­
ity of thymic alterations with the degree of immunosuppression to dinitro- 
chlorobenzene (DNCB) sensitization; 4) to correlate the recovery of a 
previously suppressed thymus with the recovery of the immune response 
upon cessation of PH treatment.
1. Guinea pigs treated with 21 daily injections of PH at dosage 
levels of 35 and 55 mg/Kg exhibited severe degrees of toxicity and high 
mortality; animals receiving 15 mg/Kg exhibited no toxic reactions and 
appeared to be unaffected. Animals receiving 25 mg/Kg of PH for 21 con­
secutive days followed by 6 supplemental injections every other day exhi­
bited marked immunosuppression and manifested acceptable degrees of toxi­
city (mild anemia, retarded weight gain) and mortality (15%). The high­
est percentages of mortality occurred in animals undergoing the longest 
duration of treatment.
2. Guinea pigs treated with 25 mg/Kg for 7, 14, or 21 consecu­
tive days exhibited marked cortical thymic lymphocyte depletion with
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minimal evidence of in situ destruction. This depletion involved small, 
medium and large sized lymphocytes; depletion was less severe in the 
medulla. Cortical epithelial cells exhibited progressive morphological 
alterati ons wi th some degenerati on in situ as early as 7 days after i ni - 
tiation of PH treatment. Cortical and medullary epithelial cells exhi­
bited the most severe damage at 14 days.
3. Guinea pigs treated with PH for 21 consecutive days prior 
to DNCB sensitization demonstrated marked degrees of immunosuppression 
when skin tested at various time intervals post-sensitization. The time 
at which the greatest degree of immunosuppression occurred differed accord­
ing to the method used to evaluate the skin test site, i . £ . , diameter, 
induration, cellular in filtration.
4. Tissue from DNCB sensitized PH treated animals demonstrated 
replenishment of thymic cortex as early as 10 days following the last 
daily injection of PH and only 3 days after their last exposure to DNCB 
sensitization. This early replenishment involved a mixture of small, 
medium and large sized thymic lymphocytes. Thymi from PH treated animals 
sacrificed 28 days after completion of daily PH treatment and 24 hours 
after completion of DNCB sensitization demonstrated an overcompencatory 
replenishment of small lymphocytes.
These observations indicate that 25 mg/Kg of PH is an effective 
immunosuppressive dose level for guinea pigs and will induce severe cor­
tical thymic lymphocyte depletion with epithelial cell damage. These 
thymic changes are accompanied by marked immunosuppression to DNCB sensi­
tization. Replenishment of the thymic cortex with lymphocytes and recov­
ery from the immunosuppressed state occur promptly upon withdrawal of PH 
treatment.
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